Recombinant multi-species ZWINT protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ZWINT protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a protein that is clearly involved in kinetochore function although an exact role is not known. It interacts with ZW10, another kinetochore protein, possibly regulating the association between ZW10 and kinetochores. The encoded protein localizes to prophase kinetochores before ZW10 does and it remains detectable on the kinetochore until late anaphase. It has a uniform distribution in the cytoplasm of interphase cells. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 2010007E07Rik,2600001N01Rik,D10Ertd749e,HZwint-1,KNTC2AP,Outer kinetochore KNL1 complex subunit ZWINT,SIP30,Sip30,ZW10 interactor,ZW10-interacting protein 1 (Zwint-1),ZWINT,ZWINT1,Zwint,Zwint-1
Go
to ZWINT products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T95621-Ag-1/ GM-Tg-hg-T95621-Ag-2 | Human ZWINT protein | Human |
| GM-Tg-rg-T95621-Ag-1/ GM-Tg-rg-T95621-Ag-2 | Rat ZWINT protein | Rat |
| GM-Tg-mg-T95621-Ag-1/ GM-Tg-mg-T95621-Ag-2 | Mouse ZWINT protein | Mouse |
| GM-Tg-cynog-T95621-Ag-1/ GM-Tg-cynog-T95621-Ag-2 | Cynomolgus/Rhesus macaque ZWINT protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T95621-Ag-1/ GM-Tg-felg-T95621-Ag-2 | Feline ZWINT protein | Feline |
| GM-Tg-cang-T95621-Ag-1/ GM-Tg-cang-T95621-Ag-2 | Canine ZWINT protein | Canine |
| GM-Tg-bovg-T95621-Ag-1/ GM-Tg-bovg-T95621-Ag-2 | Bovine ZWINT protein | Bovine |
| GM-Tg-equg-T95621-Ag-1/ GM-Tg-equg-T95621-Ag-2 | Equine ZWINT protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T95621-Ag-1/ GM-Tg-hg-T95621-Ag-2;
GM-Tg-rg-T95621-Ag-1/ GM-Tg-rg-T95621-Ag-2;
GM-Tg-mg-T95621-Ag-1/ GM-Tg-mg-T95621-Ag-2; GM-Tg-cynog-T95621-Ag-1/ GM-Tg-cynog-T95621-Ag-2; GM-Tg-felg-T95621-Ag-1/ GM-Tg-felg-T95621-Ag-2; GM-Tg-cang-T95621-Ag-1/ GM-Tg-cang-T95621-Ag-2; GM-Tg-bovg-T95621-Ag-1/ GM-Tg-bovg-T95621-Ag-2; GM-Tg-equg-T95621-Ag-1/ GM-Tg-equg-T95621-Ag-2 |
| Products Name | ZWINT protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | ZWINT |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ZWINT protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.